David Handler - Corindus Vascular CEO and President and Director
CEO
Mr. David M. Handler is appointed as President Chief Executive Officer Director of the Company effective August 12 2014. From October 2008 to August 12 2014 Mr. Handler served as Chief Executive Officer President and director of Corindus Inc. Prior to joining Corindus Inc. Mr. Handler served in General Manager positions at General Electric from October 1998 until September 2008. Mr. Handler has over 30 years of service in sales marketing and leadership roles in the medical device healthcare and plastics industries. Mr. Handler earned a B.A. in Economics from Union College in Schenectady New York and completed an Executive Leadership and Management Program at the GE Management Development Institute including his Six Sigma certification. Mr. Handler is also a board member and officer of Organization for Occupational Radiation Safety in Interventional Flouroscopy a nonprofit that raises awarness of health risks associated with occupational ionizing radiation exposure. since 2014.
| Age | 54 |
| Tenure | 10 years |
| Phone | 508 653-3335 |
| Web | www.corindus.com |
Corindus Vascular Management Efficiency
The company has return on total asset (ROA) of (0.0117) % which means that it has lost $0.0117 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0278) %, meaning that it created substantial loss on money invested by shareholders. Corindus Vascular's management efficiency ratios could be used to measure how well Corindus Vascular manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 15.43 M in liabilities with Debt to Equity (D/E) ratio of 86.5, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Corindus Vascular has a current ratio of 2.95, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Corindus Vascular until it has trouble settling it off, either with new capital or with free cash flow. So, Corindus Vascular's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Corindus Vascular sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Corindus to invest in growth at high rates of return. When we think about Corindus Vascular's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 6 records | CEO Age | ||
| Vivekanan Sankaran | Albertsons Companies | 57 | |
| Dean Banks | Tyson Foods | 46 | |
| Donald Smith | Tyson Foods | 55 | |
| James Donald | Albertsons Companies | 66 | |
| Noel White | Tyson Foods | 66 | |
| Duncan Hon | Emerson Radio | 58 | |
Management Performance
| Return On Equity | -0.0278 | |||
| Return On Asset | -0.0117 |
Corindus Vascular Leadership Team
Elected by the shareholders, the Corindus Vascular's board of directors comprises two types of representatives: Corindus Vascular inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Corindus. The board's role is to monitor Corindus Vascular's management team and ensure that shareholders' interests are well served. Corindus Vascular's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Corindus Vascular's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Scott Madden, IR Contact Officer | ||
| Hillel Bachrach, Director | ||
| David White, Director | ||
| Jeffrey Gold, Director | ||
| Gerard Winkels, Director | ||
| Campbell Rogers, Director | ||
| John Bakewell, Director | ||
| David Handler, CEO and President and Director | ||
| Jeffrey Lightcap, Chairman of the Board | ||
| Douglas Teany, COO | ||
| Michael Mashaal, Director | ||
| James Tobin, Director | ||
| Louis Cannon, Director | ||
| Mark Toland, CEO, Director | ||
| David Long, CFO, Sr. VP, Treasurer and Secretary | ||
| Aquilla Turk, Chief Medical Officer |
Corindus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Corindus Vascular a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0278 | |||
| Return On Asset | -0.0117 | |||
| Profit Margin | (33.32) % | |||
| Operating Margin | (224.79) % | |||
| Current Valuation | 892.52 M | |||
| Shares Outstanding | 208.53 M | |||
| Shares Owned By Insiders | 23.78 % | |||
| Shares Owned By Institutions | 45.96 % | |||
| Number Of Shares Shorted | 8.7 M | |||
| Price To Earning | (6.51) X |
Pair Trading with Corindus Vascular
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Corindus Vascular position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corindus Vascular will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Nasdaq could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nasdaq when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nasdaq - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nasdaq Inc to buy it.
The correlation of Nasdaq is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nasdaq moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nasdaq Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nasdaq can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Corindus Stock
If you are still planning to invest in Corindus Vascular check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Corindus Vascular's history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |